Stock comparison
Intuitive Surgical
ResMed
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ISRG
Intuitive Surgical
Market cap
$149.15B
Sector
Healthcare
RMD
ResMed
Market cap
$29.57B
Sector
Healthcare
Overall winner
Intuitive Surgical ISRG
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ISRG | RMD | Winner |
|---|---|---|---|
| Warren Buffett | 56C | 64C | RMD |
| Benjamin Graham | 81A | 67B | ISRG |
| Philip Fisher | 71B | 67B | ISRG |
| Peter Lynch | 68B | 50C | ISRG |
| Joel Greenblatt | 53C | 39D | ISRG |
| Charlie Munger | 61C | 61C | Tie |
| Terry Smith | 58C | 65B | RMD |
Side-by-side metrics
| Metric | ISRG | RMD |
|---|---|---|
| Market cap | $149.15B | $29.57B |
| P/E (TTM) | 50.2x | 19.6x |
| EV/EBIT | 49.9x | 17.1x |
| ROIC (TTM) | 16.49% | 19.63% |
| Gross margin | 66.29% | 61.69% |
| Net margin | 28.15% | 27.44% |
| Revenue CAGR 5y | 15.22% | 12.64% |
| EPS CAGR 5y | 13.68% | 30.73% |
| Debt / Equity | - | 0.1x |
| Dividend yield | 0.0% | 1.14% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ISRG leads on
- Debt / Equity-vs 0.1x+100%
- Market cap$149.15Bvs $29.57B+80%
- Revenue CAGR 5y15.22%vs 12.64%+17%
- Gross margin66.29%vs 61.69%+7%
RMD leads on
- Dividend yield1.14%vs 0.0%+100%
- EV/EBIT17.1xvs 49.9x+66%
- P/E (TTM)19.6xvs 50.2x+61%
- EPS CAGR 5y30.73%vs 13.68%+55%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.